Characteristics of percutaneous core biopsies adequate for next generation genomic sequencing

Sharjeel H. Sabir, Savitri Krishnamurthy, Sanjay Gupta, Gordon B. Mills, Wei Wei, Andrea C. Cortes, Kenna R. Mills Shaw, Rajyalakshmi Luthra, Michael J. Wallace

    Research output: Contribution to journalArticle

    9 Scopus citations

    Abstract

    Purpose Determine the characteristics of percutaneous core biopsies that are adequate for a next generation sequencing (NGS) genomic panel. Materials and methods All patients undergoing percutaneous core biopsies in interventional radiology (IR) with samples evaluated for a 46-gene NGS panel during 1-year were included in this retrospective study. Patient and procedure variables were collected. An imaging-based likelihood of adequacy score incorporating targeting and sampling factors was assigned to each biopsied lesion. Univariate and multivariate logistic regression was performed. Results 153 patients were included (58.2% female, average age 59.5 years). The most common malignancy was lung cancer (40.5%), most common biopsied site was lung (36%), and average size of biopsied lesions was 3.8 cm (+/- 2.7). Adequacy for NGS was 69.9%. Univariate analysis showed higher likelihood of adequacy score (p = 0.004), primary malignancy type (p = 0.03), and absence of prior systemic therapy (p = 0.018) were associated with adequacy for NGS. Multivariate analysis showed higher adequacy for lesions with likelihood of adequacy scored 3 (high) versus lesions scored 1 (low) (OR, 7.82; p = 0.002). Melanoma lesions had higher adequacy for NGS versus breast cancer lesions (OR 9.5; p = 0.01). Absence of prior systemic therapy (OR, 6.1; p = 0.02) and systemic therapy </ = 3 months (OR 3.24; p = 0.01) compared to systemic therapy >3 months before biopsy yielded greater adequacy for NGS. Lesions <3 cm had greater adequacy for NGS than larger lesions (OR 2.72, p = 0.02). Conclusion As targeted therapy becomes standard for more cancers, percutaneous biopsy specimens adequate for NGS genomic testing will be needed. An imaging-based likelihood of adequacy score assigned by IR physicians and other pre-procedure variables can help predict the likelihood of biopsy adequacy for NGS.

    Original languageEnglish (US)
    Article numbere0189651
    JournalPloS one
    Volume12
    Issue number12
    DOIs
    StatePublished - Dec 2017

    ASJC Scopus subject areas

    • Biochemistry, Genetics and Molecular Biology(all)
    • Agricultural and Biological Sciences(all)
    • General

    Fingerprint Dive into the research topics of 'Characteristics of percutaneous core biopsies adequate for next generation genomic sequencing'. Together they form a unique fingerprint.

  • Cite this

    Sabir, S. H., Krishnamurthy, S., Gupta, S., Mills, G. B., Wei, W., Cortes, A. C., Mills Shaw, K. R., Luthra, R., & Wallace, M. J. (2017). Characteristics of percutaneous core biopsies adequate for next generation genomic sequencing. PloS one, 12(12), [e0189651]. https://doi.org/10.1371/journal.pone.0189651